Taken together, our results showed that activation of IL-11/IL-11R/STAT3 anti-apoptotic signaling could augment lung adenocarcinoma cells resistance to cisplatin-induced apoptosis by upregulating Bcl-2 and Survivin (Fig. 6). The gene discussed is BIRC5; the disease is lung adenocarcinoma.